방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 동종이형 약물동태학적 스케일링× | 생리학 기반 약동학 (Physiologically Based Pharmacokinetics)× | |
|---|---|---|
| 분야 | 약리학 | 약리학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1989 | 1997 |
| 창시자≠ | John Mordenti | Ivan Nestorov |
| 유형≠ | inter-species extrapolation | predictive modeling |
| 원전≠ | Mordenti, J., & Chappell, W. (1989). The use of allometric scaling in toxicokinetic studies. Fundamental and Applied Toxicology, 13(2), 335-346. link ↗ | Nestorov, I. (1997). Sensitivity analysis of pharmacokinetic and pharmacodynamic systems. Journal of Pharmacokinetics and Biopharmaceutics, 25(4), 529-543. link ↗ |
| 별칭≠ | allometric scaling, inter-species extrapolation, FIH dose prediction | PBPK, PBPK modeling |
| 관련 | 3 | 3 |
| 요약≠ | Allometric scaling is a mathematical approach for predicting human pharmacokinetics from preclinical animal data using body weight relationships. Developed systematically by Mordenti and colleagues in the late 1980s, it enables rational first-in-human dose prediction without assuming species-specific metabolic differences. | PBPK is a mechanistic modeling framework that uses physiological parameters, tissue properties, and drug-specific attributes to predict drug concentration time profiles in the body. Developed rigorously in the 1990s by researchers including Nestorov, PBPK integrates anatomy, biochemistry, and kinetics to enable rational drug development, bridging in vitro data to clinical outcomes. |
| ScholarGate데이터셋 ↗ |
|
|